Eyenovia Inc (EYEN)
0.7499
-0.07
(-8.65%)
USD |
NASDAQ |
May 17, 16:00
0.7499
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Shareholders Equity (Quarterly): 1.818M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.818M |
| December 31, 2023 | 8.999M |
| September 30, 2023 | 15.78M |
| June 30, 2023 | 10.52M |
| March 31, 2023 | 15.81M |
| December 31, 2022 | 17.23M |
| September 30, 2022 | 20.33M |
| June 30, 2022 | 23.61M |
| March 31, 2022 | 29.79M |
| December 31, 2021 | 20.47M |
| September 30, 2021 | 4.246M |
| June 30, 2021 | 8.991M |
| March 31, 2021 | 12.14M |
| December 31, 2020 | 15.30M |
| Date | Value |
|---|---|
| September 30, 2020 | 18.65M |
| June 30, 2020 | 8.319M |
| March 31, 2020 | 12.33M |
| December 31, 2019 | 11.74M |
| September 30, 2019 | 16.40M |
| June 30, 2019 | 7.618M |
| March 31, 2019 | 12.46M |
| December 31, 2018 | 16.88M |
| September 30, 2018 | 19.74M |
| June 30, 2018 | 23.54M |
| March 31, 2018 | 26.86M |
| December 31, 2017 | 5.091M |
| September 30, 2017 | 0.6855M |
| December 31, 2016 | 3.009M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.818M
Minimum
Mar 2024
29.79M
Maximum
Mar 2022
14.01M
Average
13.81M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Alpine Immune Sciences Inc | 332.70M |
| Lantern Pharma Inc | 35.77M |
| Oragenics Inc | 3.168M |
| MAIA Biotechnology Inc | -5.765M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.18M |
| Total Liabilities (Quarterly) | 24.36M |
| Debt to Equity Ratio | 8.205 |
| Current Ratio | 0.878 |
| Net Debt Paydown Yield | -2.65% |